Soluble Fibrin Inhibits Lymphocyte Adherence and Cytotoxicity Against Tumor Cells: Implications for Cancer Metastasis and Immunotherapy

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical and applied thrombosis/hemostasis

• Publication date

  2008-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1076029607305619PMID 18160582
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

  2006cited by this paper
• Mechanisms of Cancer-Induced Thrombosis in Cancer

  2006cited by this paper
• Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival

  2006cited by this paper
• Soluble fibrin inhibits monocyte adherence and cytotoxicity against tumor cells: implications for cancer metastasis

  2006cited by this paper
• Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma.

  2006cited by this paper
• Tissue factor is a useful prognostic factor of recurrence in hepatocellular carcinoma in 5-year survivors.

  2005cited by this paper
• The prothrombotic state in cancer: pathogenic mechanisms.

  2004cited by this paper
• Soluble fibrin augments platelet/tumor cell adherence in vitro and in vivo, and enhances experimental metastasis

  2004cited by this paper
• Systemic coagulation reactivation in recurrence of colorectal cancer

  2003cited by this paper
• Laboratory Diagnosis of the Thrombophilic State in Cancer Patients

  1999cited by this paper
• Specific binding of integrin alpha v beta 3 to the fibrinogen gamma and alpha E chain C-terminal domains.

  1999cited by this paper
• Specific binding of integrin αvβ3 to the fibrinogen γ and α(E) chain C-terminal domains

  1999cited by this paper
• Identification of a Novel Recognition Sequence for Integrin αMβ2 within the γ-chain of Fibrinogen*

  1998cited by this paper
• Soluble fibrin in plasma before and after surgery for benign and malignant colorectal disease.

  1995cited by this paper
• Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1-fibrinogen recognition.

  1995cited by this paper
• Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis

  1993cited by this paper
• CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen.

  1991cited by this paper
• Fibrin formation inhibits the in vitro cytotoxic activity of human natural and lymphokine-activated killer cells.

  1990cited by this paper
• [Plasma fibrinogen in female patients with genital cancer and its early stage].

  1985cited by this paper
• Immunosuppression by micromolecular fibrinogen degradation products in cancer

  1976cited by this paper

• Fibrin Monomer in Thrombosis and Haemostasis: A Clinical Biomarker and Beyond

  2025cites this paper
• Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma?

  2022cites this paper
• Preoperative low absolute lymphocyte count to fibrinogen ratio correlated with poor survival in nonmetastatic colorectal cancer

  2022cites this paper
• The Action of the Pulsed Electric Field of the Subnanosecond Range on Human Tumor Cells

  2022cites this paper
• EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis

  2020cites this paper
• Vimentin prevents a miR-dependent negative regulation of tissue factor mRNA during epithelial–mesenchymal transitions and facilitates early metastasis

  2020cites this paper
• Epithelial–mesenchymal plasticity and circulating tumor cells: Travel companions to metastases

  2018cites this paper
• The intertwined fates of inflammation and coagulation in glioma

  2018cites this paper
• An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients.

  2015cites this paper
• Anticancer Property of Bromelain With Therapeutic Potential in Malignant Peritoneal Mesothelioma

  2013cites this paper
• The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression

  2013cites this paper
• Fibrin serves as a divalent ligand that regulates neutrophil-mediated melanoma cells adhesion to endothelium under shear conditions.

  2012cites this paper
• The impact of plasma fibrinogen levels on patients with vulvar cancer.

  2012cites this paper
• Modeling the effect of soluble fibrin on the immune-tumor interaction

  2011cites this paper
• Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives.

  2010cites this paper
• The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial

  2010cites this paper
• The Role of Soluble Fibrin in Lymphocyte and LAK Cell Adherence to and Migration across Vascular Endothelial Cells: Implications for Immunotherapy and Cancer

  2007cites this paper